Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Irbesartan in mild to moderate hypertensive patients.

Trial Profile

Irbesartan in mild to moderate hypertensive patients.

Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2011

At a glance

  • Drugs Irbesartan; Irbesartan/hydrochlorothiazide
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms I-SAVE
  • Sponsors Sanofi
  • Most Recent Events

    • 28 May 2008 Status changed from in progress to completed, according to ClinicalTrials.gov.
    • 10 Apr 2008 The expected completion date for this trial is now 1 Jun 2008 as reported by ClinicalTrials.gov.
    • 30 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top